Humana Inc. $HUM Holdings Raised by Voya Investment Management LLC

Voya Investment Management LLC lifted its position in shares of Humana Inc. (NYSE:HUM) by 84.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 290,225 shares of the insurance provider’s stock after acquiring an additional 132,712 shares during the period. Voya Investment Management LLC owned about 0.24% of Humana worth $75,508,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Elevation Point Wealth Partners LLC acquired a new stake in shares of Humana during the second quarter worth $32,000. AlphaCore Capital LLC acquired a new stake in shares of Humana in the 2nd quarter worth approximately $39,000. CVA Family Office LLC boosted its holdings in shares of Humana by 63.4% in the second quarter. CVA Family Office LLC now owns 219 shares of the insurance provider’s stock valued at $54,000 after acquiring an additional 85 shares in the last quarter. Traub Capital Management LLC acquired a new position in shares of Humana during the second quarter valued at approximately $61,000. Finally, Ransom Advisory Ltd bought a new stake in Humana during the first quarter worth approximately $66,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Price Performance

HUM stock opened at $259.70 on Friday. Humana Inc. has a one year low of $206.87 and a one year high of $315.35. The firm has a 50-day moving average of $259.48 and a two-hundred day moving average of $259.22. The firm has a market capitalization of $31.23 billion, a PE ratio of 24.34, a P/E/G ratio of 1.53 and a beta of 0.46. The company has a current ratio of 2.02, a quick ratio of 2.02 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.95 by $0.29. Humana had a net margin of 1.02% and a return on equity of 12.86%. The business had revenue of $32.65 billion for the quarter, compared to analyst estimates of $31.99 billion. During the same quarter in the previous year, the business earned $4.16 earnings per share. The firm’s revenue was up 11.1% compared to the same quarter last year. On average, analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, December 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.4%. Humana’s payout ratio is currently 33.18%.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on HUM shares. KeyCorp reaffirmed a “sector weight” rating on shares of Humana in a research note on Friday, December 12th. Morgan Stanley reaffirmed an “underperform” rating on shares of Humana in a report on Thursday. Bank of America upped their price target on shares of Humana from $280.00 to $300.00 and gave the company a “neutral” rating in a report on Friday, October 10th. Evercore ISI started coverage on shares of Humana in a research note on Monday, September 22nd. They issued an “in-line” rating and a $295.00 price objective on the stock. Finally, Jefferies Financial Group raised shares of Humana from a “hold” rating to a “buy” rating and increased their target price for the company from $253.00 to $313.00 in a research note on Friday, December 5th. Nine investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $294.32.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.